These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 200758)

  • 1. Cellular immunity to murine sarcoma virus-induced tumors as measured by macrophage migration inhibition assays.
    Landolfo S; Herberman RB; Holden HT
    J Natl Cancer Inst; 1977 Dec; 59(6):1675-83. PubMed ID: 200758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of mouse migration inhibitory factor (MIF) production form MSV-immune lymphocytes by soluble tumor-associated antigen: requirement for histocompatible macrophages.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1977 Apr; 118(4):1244-8. PubMed ID: 191532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
    Ng AK; Ames RS; McIntire RK; Herberman RB
    Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrophage-lymphocyte interaction in migration inhibition factor (MIF) production against soluble or cellular tumor-associated antigens. I. Characteristics and genetic control of two different mechanisms of stimulating MIF production.
    Landolfo S; Herberman RB; Holden HT
    J Immunol; 1978 Aug; 121(2):695-701. PubMed ID: 79613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocyte adherence inhibition response to murine sarcoma virus-induced tumors. II. Requirement for T-cell subpopulations and macrophages.
    Sarlo KT; Mortensen RF
    Cell Immunol; 1983 Jul; 79(2):211-9. PubMed ID: 6307531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
    Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
    Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular immunity in rats with primary brain tumors: inhibition of macrophage migration by soluble extracts of avian sarcoma virus-induced tumors.
    Adams DO; Gilbert RW; Bigner DD
    J Natl Cancer Inst; 1976 Jun; 56(6):1119-23. PubMed ID: 186622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of the immune response in tumor-bearing mice. II. Characterization of adherent suppressor cells.
    Bluestone JA; Lopez C
    J Natl Cancer Inst; 1979 Nov; 63(5):1221-7. PubMed ID: 228106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of in vitro growth of lymphoma cells by macrophages from tumor-bearing mice.
    Kirchner H; Holden HT; Herberman RB
    J Natl Cancer Inst; 1975 Oct; 55(4):971-5. PubMed ID: 171434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional heterogeneity and T cell-dependent activation of macrophages from murine sarcoma virus (MSV)-induced tumors.
    Holden HT; Varesio L; Taniyama T; Puccetti P
    Adv Exp Med Biol; 1979; 121B():509-20. PubMed ID: 232622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
    Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
    Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective cytotoxic T-cell generation in Moloney murine sarcoma virus-infected A/Sn mice.
    Becker S; Klein E
    J Natl Cancer Inst; 1980 Oct; 65(4):811-6. PubMed ID: 6968372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Correlation between cytotoxic lymphocytes and cells that synthesize the macrophage migration inhibitory factor in the H-2 system].
    Suslov AP; Egorova SG; Brondz BD
    Biull Eksp Biol Med; 1975 Oct; 80(10):86-90. PubMed ID: 776251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibition as a correlate of cell-mediated immunity to herpes simplex virus type 2 in mice.
    Mogensen SC
    Immunobiology; 1982; 162(1):28-38. PubMed ID: 6286467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of cytotoxic T-lymphocytes and producers of the macrophage migration inhibition factor (MIF) in the H-2 system.
    Brondz BD; Suslov AP; Egorova SC
    Scand J Immunol; 1978; 8(2):109-18. PubMed ID: 360371
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity to solubilized tumor antigens of a methylcholanthrene-induced sarcoma with a migration inhibition assay.
    Padarathsingh ML; Dean JH; McCoy JL; Lewis DD; Northing JW; Natori T; Law LW
    J Immunol; 1978 Jun; 120(6):1981-5. PubMed ID: 659888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell-dependent reactivity against tumor-associated antigens on allogeneic target cells.
    Holden HT; Landolfo S; Herberman RB
    Transplant Proc; 1977 Mar; 9(1):1149-52. PubMed ID: 194368
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunity to murine sarcoma virus-inducted tumors. I. Specific T lymphocytes active in macrophage migration inhibition and lymphocyte transformation.
    Gorczynski RM
    J Immunol; 1974 May; 112(5):1815-25. PubMed ID: 4361977
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization to effector lymphocytes associated with immunity to murine sarcoma virus (MSV)-induced tumors. II. Repeated stimulation and proliferation in vitro of specific cytolytic T lymphocytes.
    Plata F; Jongeneel CV
    J Immunol; 1977 Aug; 119(2):623-9. PubMed ID: 196025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.